{
    "clinical_study": {
        "@rank": "65474", 
        "arm_group": [
            {
                "arm_group_label": "rTMS-rTMS", 
                "arm_group_type": "Experimental", 
                "description": "subjects receiving real rTMS treatment and real rTMS maintenance sessions"
            }, 
            {
                "arm_group_label": "sham - sham", 
                "arm_group_type": "Sham Comparator", 
                "description": "subjects receiving sham treatment and presenting a clinical improvement : they will be submitted to sham maintenance sessions"
            }, 
            {
                "arm_group_label": "rTMS-sham", 
                "arm_group_type": "Sham Comparator", 
                "description": "subjects receiving sham rTMS maintenance sessions after successful real rTMS treatment"
            }, 
            {
                "arm_group_label": "rTMS", 
                "arm_group_type": "Experimental", 
                "description": "real rTMS for 3 weeks but without clinical improvement"
            }, 
            {
                "arm_group_label": "sham", 
                "arm_group_type": "Sham Comparator", 
                "description": "sham treatment for 3 weeks without clinical improvement"
            }
        ], 
        "brief_summary": {
            "textblock": "Maintenance rTMS sessions after a successful 3week-rTMS treatment for subjects with\n      fibromyalgia may maintain the clinical improvement."
        }, 
        "brief_title": "Efficiency of Repetitive Transcranial Magnetic Stimulation (rTMS) Sessions After a Successful 3 Week-treatment in Fibromyalgia", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Fibromyalgia", 
        "condition_browse": {
            "mesh_term": [
                "Fibromyalgia", 
                "Myofascial Pain Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "In a previous pilot study, a 3 week treatment with rTMS in fibromyalgia subjects induced a\n      40% improvement of pain feeling. Three months later, the pain level was still significantly\n      reduced in comparison with the beginning of the treatment, but the clinical improvement was\n      less than at the end of the treatment. We thus propose to realize real or sham rTMS sessions\n      at 3 weeks interval during 6 months with subjects presenting a significant clinical\n      improvement after a 3 week-rTMS or sham treatment to evaluate the response maintenance."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  presence of the criteria from the American College of Rheumatology (2010)for\n             fibromyalgia diagnosis,\n\n          -  painful state for more than six months,\n\n          -  visual analogic scale evaluation > or = 5,\n\n          -  age between 18 and 70,\n\n          -  no modification in therapeutic treatment one month before and during the protocol\n\n          -  presence of actual or prior antalgic chronic treatment : pregabalin, duloxetine,\n             milnacipran, gabapentin, venlafaxine, laroxyl, grade 1 or 2 antalgic\n\n          -  residence in Limoges or the periphery, or the ability to come to the hospital for the\n             treatment\n\n        Exclusion Criteria:\n\n          -  presence of non stabilized psychiatric comorbidity (personality trouble, addiction,\n             suicide attempt, non controlled affective trouble),\n\n          -  active epilepsy,\n\n          -  previous cerebral traumatism, or cerebral surgery, intra-cranial hyper tension,\n\n          -  pacemaker, metallic pieces in the brain, cochlear ocular implant, or any metallic\n             material contra indicating magnetic resonance imaging.\n\n          -  clozapine, bupropion, methadon, theophyllin, or other non chemical antalgic technic\n             established during the previous month(kinesitherapy, relaxation, hypnosis...),\n\n          -  pregnancy, or administrative and judiciary protection, absence of health insurance."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "78", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01942538", 
            "org_study_id": "2013-A00820-45"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "rTMS-rTMS", 
                    "rTMS-sham", 
                    "rTMS"
                ], 
                "description": "one session : 20 runs of 10 seconds high frequency stimulation(10Hz) and 50 seconds pause - power equivalent to 90% of the motor threshold", 
                "intervention_name": "rTMS", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "sham - sham", 
                    "rTMS-sham", 
                    "sham"
                ], 
                "description": "same session as defined with the real rTMS, but with a coil not delivering magnetic field.", 
                "intervention_name": "sham rTMS", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "rTMS", 
            "fibromyalgia", 
            "sham", 
            "maintenance session", 
            "pain"
        ], 
        "lastchanged_date": "May 20, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "zip": "87000"
                    }, 
                    "name": "Centre Hospitalier Esquirol"
                }, 
                "investigator": {
                    "last_name": "Dominique Malauzat, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "zip": "87000"
                    }, 
                    "name": "Centre Hospitalier Universitaire"
                }, 
                "investigator": [
                    {
                        "last_name": "Pascale Vergne-Salle, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Philippe Bertin, MD, PhD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "5", 
        "official_title": "Study of the Effectiveness of Maintenance rTMS Sessions for 6 Months Versus Placebo in Subjects With Fibromyalgia Responders to 3 Week-rTMS Treatment", 
        "overall_contact": {
            "email": "j.christophe.dumont@gmail.com", 
            "last_name": "Jean-Christophe Dumont, MD", 
            "phone": "0033555056870"
        }, 
        "overall_contact_backup": {
            "email": "murielle.girard@ch-esquirol-limoges.fr", 
            "last_name": "Murielle Girard, PhD", 
            "phone": "0033555431028"
        }, 
        "overall_official": {
            "affiliation": "CHU Dupuytren CH Esquirol", 
            "last_name": "Jean-Christophe Dumont, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "France: Committee for the Protection of Personnes"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "= number of fibromyalgia subjects maintaining a clinical improvement after a prior rTMS treatment (15 sessions in 3 weeks)and maintenance rTMS sessions administered at 42, 63, 84, 105, 126, 147, 168, 189, 210 days after inclusion in comparison with sham maintenance sessions.\nclinical improvement is described as a 30% decrease from baseline in pain feeling (visual analogue scale) and a response \u2265 6 for the Patient's global impression of Change.\neffect will be considered as maintained if criteria of clinical improvement present after 3 week rTMS treatment are conserved at 6 months rTMS or sham maintenance sessions.", 
            "measure": "number of fibromyalgia subjects maintaining a clinical improvement with rTMS maintenance sessions during 6 months", 
            "safety_issue": "No", 
            "time_frame": "210 days"
        }, 
        "reference": {
            "PMID": "23673085", 
            "citation": "Ciobanu C, Girard M, Marin B, Labrunie A, Malauzat D. rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: Effectiveness and effects of age. J Affect Disord. 2013 Sep 5;150(2):677-81. doi: 10.1016/j.jad.2013.03.024. Epub 2013 May 11."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01942538"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre Hospitalier Esquirol", 
            "investigator_full_name": "Jean-Christophe Dumont", 
            "investigator_title": "Medical Doctor, Assistant in Rheumatologia Service  CHU Limoges", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "number of rTMS responders at 3week-rTMS treatment", 
            "safety_issue": "No", 
            "time_frame": "21 days"
        }, 
        "source": "Centre Hospitalier Esquirol", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Esquirol", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}